Ordering Publications

To order a hard copy of any of the publications listed below from UCLA ISAP, send the article number (found at the end of the reference, for example "12.1"), the article author/title, and your postal address to:

Kris Langabeer
UCLA Integrated Substance Abuse Programs
1640 S. Sepulveda Blvd., Ste. 200
Los Angeles, CA 90025-7535

Your first 5 articles ordered per year are free, but additional articles are $1 per reprint. Checks should be made out to "UC Regents." Purchase orders will not be accepted for orders under $25.

Publications List (A-C)

(A list of all publications is available as an .rtf file).

Adams, E., Brodsky, M., Gropper, B., & Anglin, M. D. (1988). Interagency workshop-conference on prevalence estimation techniques. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (12.1)

Adler, L. E., Olincy, A., Cawthra, E., Hoffer, M., Nagamoto, H. T., Amass, L., & Freedman, R. (2001). Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology, 24(6), 671-679. (04.44)

Alessi, S. M., Roll, J. M., Reilly, M. P., & Johanson, C. E. (2002). Establishment of a diazepam preference in human volunteers following a differential-conditioning history of placebo versus diazepam choice. Experimental and Clinical Psychopharmacology, 10(2), 77-83. (27.15)

Alessi, S. M., Roll, J. M., Reilly, M. P., & Johanson, C. E. (2002). Establishment of a diazepam preference in human volunteers following a differential-conditioning history of placebo versus diazepam choice: Reply to Bouton (2002), Carroll (2002), Chilcoat (2002), Kelly (2002), Stewart (2002), and Vuchinich (2002). Experimental and Clinical Psychopharmacology, 10(2), 101-103. (27.16)

Almog, Y. J., Anglin, M. D., & Fisher, D. G. (1993). Alcohol and heroin use patterns of narcotics addicts: Gender and ethnic differences. American Journal of Drug and Alcohol Abuse, 19(2), 219-238. (02.7)

Amass, L., Bickel, W. K., Crean, J. P., Blake, J., & Higgins, S. T. (1998). Alternate-day buprenorphine dosing is preferred to daily dosing by opioid-dependent humans. Psychopharmacology, 136(3), 217-225. (29.4)

Amass, L., Bickel, W. K., Crean, J. P., & Higgins, S. T. (1996). Preferences for clinic privileges, retail items and social activities in an outpatient buprenorphine treatment program. Journal of Substance Abuse Treatment, 13(1), 43-49. (29.3)

Amass, L., Bickel, W. K., Higgins, S. T., & Badger, G. J. (1994). Alternate-day dosing during buprenorphine treatment of opioid dependence. Life Sciences, 54(17), 1215-1228. (29.11)

Amass, L., Bickel, W. K., Higgins, S. T., Budney, A. J., & Foerg, F. E. (1993). The taking of free condoms in a drug abuse treatment clinic: The effects of location and posters. American Journal of Public Health, 83(10), 1466-1468. (18.96)

Amass, L., Bickel, W. K., Higgins, S. T., & Hughes, J. R. (1994). A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification. Journal of Addictive Diseases, 13(3), 33-45. (29.14)

Amass, L., Kamien, J. B., & Mikulich, S. K. (2000). Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug and Alcohol Dependence, 58(1-2), 143-152. (29.1)

Amass, L., Kamien, J. B., & Mikulich, S. K. (2001). Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans. Drug and Alcohol Dependence, 61(2), 173-181. (29.2)

Amass, L., Nardin, R., Mendelson, J. H., Teoh, S. K., & Woods, B. T. (1992). Quantitative magnetic resonance imaging in heroin- and cocaine-dependent men: A preliminary study. Psychiatry Research: Neuroimaging, 45(1), 15-23. (29.13)

Aneshensel, C., Anglin, M. D., Brown, R., Cousineau, M., Dallek, G., Fiorentine, R., Freed, J., Halfon, N., Leslie, J., Pollack, S., Pridgen, J., Sorenson, S., Upchurch, D., Visscher, B., & Wallace, S. (1993). Inequalities in health: "The sickness in the center of our cities". In: A. J. Scott, & R. Brown (Eds.), South-Central Los Angeles: Anatomy of an urban crisis (pp. 43-88). Los Angeles: Lewis Center for Regional Policy Studies. (13.8)

Angell, J. L. (1993). Initial process evaluation and participant profile of the Bay Area Services Network (BASN). Unpublished manuscript, California Department of Corrections: (06.34)

Anglin, M. D. (1982). Alcohol and criminality. In: E. M. Pattison, & E. Kaufman (Eds.), Encyclopedia handbook of alcoholism (pp. 383-394). New York: Gardner Press. (02.1)

Anglin, M. D. (1987). Book reviews [Review of the book Alcohol and aggression, 2nd edition]. Journal of Studies of Alcohol, 48(3), 281-282. (02.3)

Anglin, M. D. (1984). Book reviews [Review of the book Alcohol, drug abuse and aggression, 2nd edition]. Journal of Studies of Alcohol, 45(5), 469. (02.2)

Anglin, M. D. (1989). Civil commitment as a model for reducing drug demand. In: J. Scher, & M. Segal (Eds.), Perspectives in Drug Abuse, Vol. 1 (pp. 225-235). London: Freund Publishing House, Ltd. (03.7)

Anglin, M. D. (1989). Compulsory treatment for opiate dependence: Reviews of findings and social policy implications. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (18.6)

Anglin, M. D. (1994). Drug use and crime. In: A. J. Lurigio, & G. J. Bensinger (Eds.), Drugs and community corrections (pp. 85-94). Chicago: Loyola University. (06.20)

Anglin, M. D. (1988). The efficacy of civil commitment in treating narcotic addiction. In: C. G. Leukefeld, & F. M. Tims (Eds.), Compulsory treatment of drug abuse: Research and clinical practice (NIDA Research Monograph 86, pp. 8-34). Rockville, MD: National Institute on Drug Abuse. (03.5)

Anglin, M. D. (1990). Ensuring success in corrections-based interventions with drug-abusing populations. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (06.10)

Anglin, M. D. (1995). A methodological review of the California Drug and Alcohol Treatment Assessment (CALDATA) study. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (18.35)

Anglin, M. D. (1990). Raising children in the twenty-first century: Drug abuse treatment to ameliorate negative family and childhood effects of parental drug abuse. Paper presented at "A seminar for executive branch employees", sponsored by the American Enterprise Institute for Public Policy Research, Williamsburg, VA. (11.4)

Anglin, M. D. (1988). A social policy analysis of compulsory treatment for opiate dependence. Journal of Drug Issues, 13(4). (18.5)

Anglin, M. D. (1986). Special section: Developments, trends and prospects in substance abuse. Journal of Drug Education, 16(3), 263. (13.1)

Anglin, M. D., Almog, Y. J., Fisher, D. G., & Peters, K. (1989). Alcohol use by heroin addicts: Evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples. American Journal of Drug and Alcohol Abuse, 15(2), 191-207. (02.4)

Anglin, M. D., Belmont, A., & Boyle, K. (1988). Etiological and epidemiological aspects of drug abuse. Paper presented at the Drug Abuse Information and Monitoring Project: AIDS outreach pilot demonstration project for neighborhood outreach workers. (08.1)

Anglin, M. D., Booth, M. W., Kao, C. F., Harlow, L. L., & Peters, K. (1987). Similarity of behavior within addict couples. Part II. Addiction-related variables. International Journal of the Addictions, 22(7), 583-607. (14.1)

Anglin, M. D., Booth, M. W., Ryan, T. M., & Hser, Y. (1988). Ethnic differences in narcotics addiction. Part II. Chicano and Anglo addiction career patterns. International Journal of the Addictions, 23(10), 1011-1027. (09.1)

Anglin, M. D., & Brecht, M. L. (1987). AIDS virus exposure in long term addicts: A preliminary study. In: L. S. Harris (Ed.), Problems of drug dependence 1986: Proceedings of the 48th annual scientific meeting, the College on Problems of Drug Dependence, Inc. (NIDA Research Monograph 76, pp. 200-206). Rockville, MD: National Institute on Drug Abuse. (01.1)

Anglin, M. D., Brecht, M. L., & Maddahian, E. (1989). Pretreatment characteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology, 27(3), 537-557. (18.10)

Anglin, M. D., Brecht, M. L., Woodward, J. A., & Bonett, D. G. (1986). An empirical study of maturing out: Conditional factors. International Journal of the Addictions, 21(2), 233-246. (18.2)

Anglin, M. D., Caulkins, J. P., & Hser, Y. (1993). Prevalence estimation: Policy needs, current status and future potential. Journal of Drug Issues, 23(2), 345-360. (12.23)

Anglin, M. D., Danila, B., Ryan, T. M., & Mantius, K. (1996). Staying in touch: A fieldwork manual of tracking procedures for locationg substance abusers for follow-up studies. Washington, D.C.: National Evaluation Data and Technical Assistance Center (NEDTAC). (20.13)

Anglin, M. D., Deschenes, E. P., & Prendergast, M. L. (1994). Ethnic and gender differences in effectiveness of legal supervision in controlling narcotics use and crime. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (09.9)

Anglin, M. D., Deschenes, E. P., & Speckart, G. R. (1988). Optimization of legal supervision for chronic addict offenders: Final report. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (10.7)

Anglin, M. D., & Fisher, D. G. (1987). Survival analysis in drug program evaluation. Part II. Partitioning treatment effects. International Journal of the Addictions, 22(4), 377-387. (16.1)

Anglin, M. D., & Hser, Y. (1988). Addict career histories: Processes and patterns. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (16.3)

Anglin, M. D., & Hser, Y. (1987). Addicted women and crime. Criminology, 25(2), 359-397. (21.1)

Anglin, M. D., & Hser, Y. (1990). Concept paper on improving measures for better estimation of drug abuse prevalence and consequences. Paper prepared for the Bureau of Justice Statistics/RAND Seminar, Washington, DC. (12.4)

Anglin, M. D., & Hser, Y. (1991). Criminal justice and the drug-abusing offender: Policy issues of coerced treatment. Behavioral Sciences and the Law, 9(3), 243-267. (06.14)

Anglin, M. D., & Hser, Y. (1992). Drug abuse treatment. In: R. R. Watson (Ed.), Drug and alcohol abuse reviews, Vol. 4 (pp. 1-36). Totowa, NJ: Humana Press. (18.21)

Anglin, M. D., & Hser, Y. (1990). Legal coercion and drug abuse treatment: Research findings and social policy implications. In: J. A. Inciardi (Ed.), Handbook of drug control in the United States (pp. 151-176). Westport, CT: Greenwood Press. (18.12)

Anglin, M. D., & Hser, Y. (1996). Outcome evaluation research. In: Drug abuse and drug abuse research: The fourth triennial report to congress from the secretary, Department of Human Services (pp. 3-1--3-7). Rockville, MD: National Institute of Drug Abuse. (13.6)

Anglin, M. D., & Hser, Y. (1991). Overview and summary of meeting. Paper presented at the Proceedings of the Prevalence Estimation Methods Workshop. Washington, DC: National Institute of Justice; Rockville, MD: National Institute on Drug Abuse. (12.8)

Anglin, M. D., & Hser, Y. (1990). Treatment of drug abuse. In: M. Tonry, & J. Q. Wilson (Eds.), Drugs and crime, Vol. 13 (pp. 393-460). Chicago: University of Chicago Press. (18.13)

Anglin, M. D., Hser, Y., & Booth, M. W. (1987). Sex differences in addict careers. 4. Treatment. American Journal Of Drug And Alcohol Abuse, 13(3), 253-280. (14.2)

Anglin, M. D., Hser, Y., Booth, M. W., Speckart, G. R., McCarthy, W. J., Ryan, T. M., & Powers, K. I. (1988). The natural history of narcotics addiction: A 25 year follow-up. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (03.6)

Anglin, M. D., Hser, Y., Brecht, M. L., Deschenes, E. P., Rodriguez, M. E., Speckart, G. R., Booth, M. W., & Powers, K. I. (1989). Summary of recent research findings. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (13.2)

Anglin, M. D., Hser, Y., & Chou, C. P. (1993). Reliability and validity of retrospective behavioral self-report by narcotics addicts. Evaluation Review, 17(1), 91-108. (12.12)

Anglin, M. D., Hser, Y., & Grella, C. E. (1997). Drug addiction and treatment careers among clients in DATOS. Psychology of Addictive Behaviors, 11(4). (18.57)

Anglin, M. D., Hser, Y., Grella, C. E., Longshore, D., & Prendergast, M. L. (1997). Drug treatment careers: Conceptual overview and application to DATOS. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center: (18.52)

Anglin, M. D., Hser, Y., Grella, C. E., Longshore, D., & Prendergast, M. L. (2001). Drug treatment careers: Conceptual overview and clinical, research, and policy applications. In: J. Platt, C. G. Leukefeld, & F. M. Tims (Eds.), Relapse and recovery processes in the addictions. New Haven, CT: Yale University Press. (18.70)

Anglin, M. D., Hser, Y., & McGlothlin, W. H. (1987). Sex differences in addict careers. 2. Becoming addicted. American Journal of Drug and Alcohol Abuse, 13(1-2), 59-71. (14.3)

Anglin, M. D., Huba, G. J., & Ziedonis, D. (1989). White paper on substance abuse research, training, and services at UCLA. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center: (13.3)

Anglin, M. D., Kalechstein, A., Maglione, M. A., Annon, J. J., & Fiorentine, R. (1998). Epidemiology and treatment of methamphetamine abuse in California: A regional report. Unpublished report, University of California, Los Angeles, Drug Abuse Research Center.: (18.68)

Anglin, M. D., Kao, C. F., Harlow, L. L., Peters, K., & Booth, M. W. (1987). Similarity of behavior within addict couples. Part I. Methodology and narcotics patterns. International Journal of the Addictions, 22(6), 497-524. (14.4)

Anglin, M. D., Kaplan, J., & Sells, S. B. (1983). Drugs and crime: Behavioral aspects. In: S. H. Kadish (Ed.), Encyclopedia of crime and justice, Vol. 2 (pp. 636-643). New York: Free Press. (06.2)

Anglin, M. D., Longshore, D., & Turner, S. (1999). Treatment alternatives to street crime: An evaluation of five programs. Criminal Justice and Behavior, 26(2), 168-195. (06.36)

Anglin, M. D., & Maugh, T. H. (1992). Ensuring success in interventions with drug-using offenders. Annals, AAPSS, 521, 66-90. (06.18)

Anglin, M. D., & Maugh, T. H. (1992). Overturning myths about coerced drug treatment. California Psychologist, 19-22. (18.22)

Anglin, M. D., & McGlothlin, W. H. (1985). Methadone maintenance in California: A decade's experience. In: L. Brill, & C. Winick (Eds.), The yearbook of substance use and abuse, Vol. III (pp. 219-280). New York : Humana Sciences Press. (10.6)

Anglin, M. D., & McGlothlin, W. H. (1984). Outcome of narcotic addict treatment in California. In: F. M. Tims, & J. P. Ludford (Eds.), Drug abuse treatment evaluation: Strategies, progress, and prospects (NIDA Research Monograph 51, pp. 106-128). Rockville, MD: National Institute on Drug Abuse. (18.1)

Anglin, M. D., McGlothlin, W. H., & Speckart, G. R. (1981). The effect of parole on methadone patient behavior. American Journal of Drug and Alcohol Abuse, 8(2), 153-170. (10.4)

Anglin, M. D., Miller, M. L., Mantius, K., & Grella, C. E. (1993). Enhanced methadone maintenance treatment: Limiting the spread of HIV among high risk Los Angeles narcotics addicts. In: J. A. Inciardi, F. M. Tims, & B. W. Fletcher (Eds.), Innovative approaches in the treatment of drug abuse: Program models and strategies (pp. 3-19). Westport, CT: Greenwood Press. (10.13)

Anglin, M. D., & Perrochet, B. (1998). Drug use and crime: A historical review of research conducted by the UCLA Drug Abuse Research Center. Substance Use and Misuse, 33(9), 1871-1914. (06.22)

Anglin, M. D., & Powers, K. I. (1990). Individual and joint effects of methadone maintenance and legal supervision on the behavior of narcotics addicts. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (10.10)

Anglin, M. D., & Powers, K. I. (1991). Methadone treatment and legal supervision: Individual and joint effects on the behavior of narcotics addicts. Special issue: Individuals and organizations. Journal of Applied Behavioral Science, 27(4), 515-531. (10.11)

Anglin, M. D., Prendergast, M. L., & Longshore, D. (1994). Nationwide TASC evaluation: Context, research objectives, and study design. Paper presented at the annual meeting, American Society of Criminology, Miami, FL. (18.25)

Anglin, M. D., Ryan, T. M., Booth, M. W., & Hser, Y. (1988). Ethnic differences in narcotics addiction. I. Characteristics of Chicano and Anglo methadone maintenance clients. International Journal of the Addictions, 23(2), 125-149. (09.2)

Anglin, M. D., Shen, H., Hser, Y., & Brecht, M. L. Drug use prevalence estimates among adult arrestees in California, Texas, and the U.S. Final report submitted to the National Evaluation and Data Technical Assistance Center, CSAT. Los Angeles, CA: UCLA Drug Abuse Research Center. (08.8)

Anglin, M. D., & Speckart, G. R. (1988). Narcotics use and crime: A multisample, multimethod analysis. Criminology, 26(2), 197-233. (06.7)

Anglin, M. D., & Speckart, G. R. (1986). Narcotics use, property crime, and dealing: Structural dynamics across the addiction career. Journal of Quantitative Criminology, 2(4), 355-375. (06.4)

Anglin, M. D., Speckart, G. R., Booth, M. W., & Ryan, T. M. (1989). Consequences and costs of shutting off methadone. Addictive Behaviors, 14(3), 307-326. (10.8)

Anglin, M. D., Speckart, G. R., & Deschenes, E. P. (1990). Reexamining the effects of probation and parole on narcotics addiction and property crime. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (06.11)

Anglin, M. D., Thompson, J. P., & Fisher, D. G. (1986). Parental, personality, and peer correlates of psychoactive mushroom use. Journal of Drug Education, 16(3), 265-285. (11.1)

Anglin, M. D., & Urada, D. (2003). The California Substance Abuse Research Consortium: Origins, history, and issues. Journal of Psychoactive Drugs, SARC Supplement 1, 109-117. (13.43)

Anglin, M. D., Weisman, C. P., & Fisher, D. G. (1989). The MMPI profiles of narcotics addicts. I. A review of the literature. International Journal of the Addictions, 24(9), 867-880. (13.4)

Anglin, M. D., & Westland, C. A. (1989). Drug monitoring in the workplace: Results from the California commercial laboratory drug testing project. In: S. W. Gust, & J. M. Walsh (Eds.), Drugs in the workplace: Research and evaluation data (NIDA Research Monograph 91, pp. 81-96). Rockville, MD: National Institute on Drug Abuse. (22.1)

Annon, K., & Anglin, M. D. (1996). Update on illicit drug use in Los Angeles County. Paper presented at the semi-annual meeting, Community Epidemiology Work Group, New York, NY. (08.2)

Annon, K., & Anglin, M. D. (1996). Update on illicit drug use in Los Angeles County. Paper presented at the semi-annual meeting, Community Epidemiology Workgroup, Los Angeles, CA.: (08.4)

Annon, K., Hoffman, V., & Anglin, M. D. (1998). Update on illicit drug use in Los Angeles County. Paper presented at the semi-annual meeting, Community Epidemiology Work Group, Los Angeles, CA. (08.7)

Annon, K., Hoffman, V., & Anglin, M. D. (1999). Update on illicit drug use in Los Angeles County. Paper presented at the semi-annual meeting, Community Epidemiology Workgroup, Los Angeles, Ca.: (08.3)

Bailey, R. C., & Berg, D. (1994). The behavioral and attitudinal modification project (BAM): A failed experiment using a classical experimental research design in a closed institutional setting for drug addicts. International Journal of the Addictions, 29(10), 1315-1345. (13.7)

Bailey, R. C., Hser, Y., Hsieh, S., & Anglin, M. D. (1994). Influences affecting maintenance and cessation of narcotics addiction. Special issue: Drugs and crime revisited. Journal of Drug Issues, 24(2), 249-272. (18.32)

Baldwin, D. M., Brecht, M. L., Monahan, G., Annon, K., & Anglin, M. D. (1995). Perceived need for treatment among pregnant and non-pregnant women arrestees. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (21.15)

Bartzokis, G., Beckson, M., Hance, D. B., Lu, P. H., Foster, J. A., Mintz, J., Ling, W., & Bridge, P. (1999). Magnetic resonance imaging evidence of "silent" cerebrovascular toxicity in cocaine dependence. Biological Psychiatry, 45(9), 1203-1211. (04.46)

Bartzokis, G., Beckson, M., & Ling, W. (1996). Clinical and MRI evaluation of psychstimulant neurotoxicity. In: Neurotoxicity and neuropathology associated with cocaine abuse (NIDA Research Monograph 163, pp. 300-317). Rockville, MD: National Institute on Drug Abuse. (18.102)

Bartzokis, G., Beckson, M., Newton, T., Mandelkern, M. A., Mintz, J., Foster, J. A., Ling, W., & Bridge, T. P. (1999). Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria. Neuropsychopharmacology, 20(6), 582-590. (04.43)

Bartzokis, G., Lu, P. H., Beckson, M., Rapoport, R., Grant, S., Wiseman, E. J., & London, E. D. (2000). Abstinence from cocaine reduces high-risk responses on a gambling task. Neuropsychopharmacology, 22(1), 102-103. (04.48)

Beck, J. E. (1987). MDMA. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (20.2)

Bickel, W. K., & Amass, L. (1995). Buprenorphine treatment of opioid dependence: A review. Experimental and Clinical Psychopharmacology, 3(4), 477-489. (29.16)

Bickel, W. K., & Amass, L. (1993). The relationship of mean daily blood alcohol levels to admission mast, clinic absenteeism and depression in alcoholic methadone patients. Drug and Alcohol Dependence, 32(2), 113-118. (02.15)

Bickel, W. K., Amass, L., Crean, J. P., & Badger, G. J. (1999). Buprenorphine dosing every 1, 2, or 3 days in opioid-dependent patients. Psychopharmacology, 146(2), 111-118. (29.5)

Bickel, W. K., Amass, L., Higgins, S. T., Badger, G. J., & Esch, R. A. (1997). Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology, 65(5), 803-810. (29.15)

Bing, E. G., Burnam, A., Longshore, D., Fleishman, J. A., Sherbourne, C. D., London, A. S., Turner, B. J., Eggan, F., Beckman, R., Vitiello, B., Morton, S. C., Orlando, M., Bozzette, S. A., Ortiz-Barron, L., & Shapiro, M. F. (2001). Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Archives of General Psychiatry, 58(8), 721-728. (01.57)

Bluthenthal, R. N., Gogineni, A., Longshore, D., & Stein, M. D. (2001). Factors associated with readiness to change drug use among needle-exchange users. Drug and Alcohol Dependence, 62(3), 225-230. (01.56)

Boles, S. M., Casas, J. M., Furlong, M., & Gonzalez, G. (1994). Alcohol and other drug use patterns among Mexican-American, Mexican, and Caucasian adolescents: New directions for assessment and research. Journal of Clinical Child Psychology, 23(1), 39-46. (02.10)

Boles, S. M., & Johnson, P. B. (2001). Gender, weight concerns, and adolescent smoking. Journal of Addictive Diseases, 20(2), 5-14. (14.13)

Boles, S. M., & Johnson, P. B. (2001). Violence among comorbid and noncomorbid severely mentally ill adults: A pilot study. Substance Abuse, 22(3), 167-173. (15.10)

Boles, S. M., & Miotto, K. (2003). Substance abuse and violence: A review of the literature. Aggression and Violent Behavior, 8, 155-174. (13.42)

Bonson, K. R., Grant, S., Contoreggi, C., Links, J. M., Metcalfe, J., Weyl, H. L., Kurian, V., Ernst, M., & London, E. D. (2002). Neural systems and cue-induced cocaine craving. Neuropsychopharmacology, 26(3), 376-386. (30.6)

Booth, M. W., & Anglin, M. D. (1990). Mortality and morbidity in narcotics addicts: A review of the literature. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (16.4)

Booth, M. W., Castro, P. G., & Anglin, M. D. (1991). What do we know about Hispanic substance abuse? A review of the literature. In: J. W. Moore, & R. Glick (Eds.), Drug use in Hispanic communities (pp. 21-43). New Brunswick, NJ: Rutgers University Press. (09.4)

Boyle, K., & Anglin, M. D. (1992). "To the curb": Sex bartering and drug use among homeless crack users in Los Angeles. In: M. Ratner (Ed.), Crack pipe as pimp: Sex for crack in eight cities (pp. 159-186). New York: Lexington Press. (04.10)

Boyle, K., Gil-Rivas, V., & Anglin, M. D. (1994). Qualitative evaluation of Buenacare's enhanced methadone treatment program. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center . (10.18)

Boyle, K., Polinsky, M. L., & Hser, Y. (2000). Resistance to drug abuse treatment: a comparison of drug users who accept or decline treatment referral assessment. Journal of Drug Issues, 30(3), 555-574. (18.91)

Brecht, M. L., & Anglin, M. D. (1990). Conditional factors of maturing out: Legal supervision and treatment. International Journal of the Addictions, 25(4), 393-407. (18.14)

Brecht, M. L., & Anglin, M. D. (1992). Conditional factors of maturing out of narcotic addiction: Long term relationships. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (18.3)

Brecht, M. L., Anglin, M. D., & Lu, T. H. (2003). Estimating drug use prevalence among arestees using ADAM data: An application of a logistic regression synthetic estimation procedure. Los Angeles: UCLA Integrated Substance Abuse Programs. Available online from the National Criminal Justice Reference Service (Document No. 198829) at http://www.ncjrs.org/pdffiles1/nij/grants/198829.pdf. (12.26)

Brecht, M. L., Anglin, M. D., & Wang, J. C. (1993). Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients. American Journal of Drug and Alcohol Abuse, 19(1), 89-106. (18.24)

Brecht, M. L., Anglin, M. D., Woodward, J. A., & Bonett, D. G. (1987). Conditional factors of maturing out: Personal resources and preaddiction sociopathy. International Journal of the Addictions, 22(1), 55-69. (18.4)

Brecht, M. L., Hser, Y., & Anglin, M. D. (1990-1991). A multimethod assessment of social intervention effects on narcotics use and property crime. International Journal of the Addictions, 25(11A), 1317-1340. (06.13)

Brecht, M. L., Ritvo, E., Arnold, J., & Anglin, M. D. (1987). Acquired immune deficiency syndrome: A review of the literature. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (01.2)

Brecht, M. L., & von Mayrhauser, C. L. (2002). Difference between Ecstasy-using and nonusing methamphetamine users. Journal of Psychoactive Drugs, 34(2), 215-223. (28.13)

Brecht, M. L., von Mayrhauser, C. L., & Anglin, M. D. (2000). Predictors of relapse after treatment for methamphetamine use. Journal of Psychoactive Drugs, 32(2), 211-220. (28.1)

Brecht, M. L., & Wickens, T. D. (1993). Application of multiple-capture methods for estimating drug use prevalence. Journal of Drug Issues, 23(2), 229-250. (12.17)

Brody, A. L., Mandelkern, M. A., London, E. D., Childress, A. R., Lee. G.S., Bota, R. G., Ho, M. L., Saxena, S., Baxter, L. R., Madsen, D., & Jarvik, M. E. (2002). Brain metabolic changes during cigarette craving. Archives of General Psychiatry, 59, 1162-1172. (30.20)

Brower, K. J., & Anglin, M. D. (1987). Adolescent cocaine use: Epidemiology, risk factors, and prevention. Journal of Drug Education, 17(2), 163-180. (04.2)

Brown, A. H., Grella, C. E., & Cooper, L. (2002). Living it or learning it: attitudes and beliefs about experience and expertise in treatment for the dually diagnosed. Contemporary Drug Problems, 29, 687-710. (15.15)

Budney, A. J., Bickel, W. K., & Amass, L. (1998). Marijuana use and treatment outcome among opioid-dependent patients. Addiction, 93(4), 493-503. (29.10)

Burdon, W. M., & Gallagher, C. A. (2002). Coercion and sex offenders: controlling sex-offending behavior through incapacitation and treatment. Criminal Justice and Behavior, 29(1), 87-109. (03.22)

Burdon, W. M., Kilian, T. C., Koutsenok, I., & Prendergast, M. L. (2001). Treating substance-abusing sex offenders in a correctional environment: Lessons for the California experience. Offender Substance Abuse Report, 1(1), 3-4, 11-12. (03.16)

Burdon, W. M., Roll, J. M., Prendergast, M. L., & Rawson, R. (2001). Drug courts and contingency management. Journal of Drug Issues, 31(1), 73-90. (27.14)

Campos, M., Prendergast, M. L., Evans, W., & Martinez, J. (2003). The California Department of Corrections Drug Reduction Strategy Project. Offender Substance Abuse Report, 3(4), 49-50, 59-60. (03.32)

Carpenter, C. L., Kowalewski, M. R., Longshore, D., Annon, K., & Anglin, M. D. (1996). Prevalence of HIV-1 among recent arrestees: Accessing a proxy group for hidden populations. Unpublished manuscript, University of California, Los Angeles, Drug Abuse Research Center. (01.26)

Carpenter, C. L., Longshore, D., Annon, K., Annon, J. J., & Anglin, M. D. (1999). Prevalence of HIV-1 among recent arrestees in Los Angeles County: Serial cross-sectional study, 1991 to 1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 21(2), 172-178. (01.37)

Carroll, K. M., Farentinos, C., Ball, S. A., Crits-Cristoph, P., Libby, B., Morganstern, J., Obert, J. L., Polcin, D., & Woody, G. E. (2002). MET meets the real world: Design issues and clinical strategies in the clinical trials network. Journal of Substance Abuse Treatment, 23(2), 73-80. (13.39)

Chapman, M.A., Roll, J.M., Park, S., Galloway, M.P. (2003). Extracellular glutamate decrease in accumbens following cued food delivery. Neuroreport, 14(7), 991-4. (20.24)

Chefer, S. I., London, E. D., Koren, A. O., Pavlova, O. A., Kurian, V., Kimes, A. S., Horti, A. G., & Mukhin, A. G. (2003). Graphical analysis of 2-[F-18]FA binding to nicotinic acetylcholine receptors in rhesus monkey brain. Synapse, 48(1), 25-34. (30.25)

Chermack, S. T., Roll, J. M., Reilly, M. P., Davis, L., Kilaru, U., & Grabowski, J. (2000). Comparison of patient self-reports and urinalysis results obtained under naturalistic methadone treatment conditions. Drug and Alcohol Dependence, 59(1), 43-49. (10.38)

Chou, C. P., Hser. Y., & Anglin, M. D. (1998). Interaction effects of client and treatment program characteristics on retention: An exploratory analysis using hierarchical linear models. Substance Use and Misuse, 33(11), 2281-2301. (24.5)

Chou, C. P., Hser, Y., & Anglin, M. D. (2003). Longitudinal treatment effects among cocaine users: A growth curve modeling approach. Substance Use and Misuse, 38(9), 1323-1343. (04.59)

Chou, C. P., Hser, Y., & Anglin, M. D. (1996). Pattern reliability of narcotics addicts' self-reported data: A confirmatory assessment of construct validity and consistency. Substance Use and Misuse, 31(9), 1189-1216. (12.6)

Chung, T., Martin, C. S., Grella, C. G., Winters, K. C., Abrantes, A. M., & Brown, S. A. (2003). Course of alcohol problems in treated adolescents. Alcoholism: Clinical and Experimental Research, 27(2), 253-261. (05.19)

Collins, C., Grella, C. E., & Hser, Y. (2003). Effects of gender and level of parental involvement among parents in drug treatment. American Journal of Drug and Alcohol Abuse, 29(2), 237-261. (14.15)

Compton, P. A., Anglin, M. D., Khalsa-Denison, M. E., & Paredes, A. (1996). The d2 dopamine receptor gene, addiction and personality: Clinical correlates in cocaine abusers. Biological Psychiatry, 39(4), 302-304. (04.28)

Compton, P. A., Charuvastra, V. C., Kintaudi, P. , & Ling, W. (2000). Pain responses in methadone-maintained opioid abusers. Journal of Pain and Symptom Management, 20(4 ), 237-245. (29.17)

Compton, P. A., Charuvastra, V. C., & Ling, W. (2001). Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent. Drug and Alcohol Dependence, 63(2), 139-146. (29.7)

Compton, P. A., Darakjian, J., & Miotto, K. (1998). Screening for addiction in patients with chronic pain and "problematic" substance use: evaluation of a pilot assessment tool. Journal of Pain and Symptom Management, 16(6), 355-363. (13.26)

Conner, B. T., Stein, J. A., Longshore, D., & Stacy, A. W. (1999). Associations between drug abuse treatment and cigarette use: evidence of substance replacement. Experimental and Clinical Psychopharmacology, 7(1), 64-71. (13.20)

Cooper, L., Brown, V. B., & Anglin, M. D. (1989). Multiple diagnosis: Aspects and issues in substance abuse. Los Angeles: Drug Abuse Information and Monitoring Project, UCLA Drug Abuse Research Center. (15.1)

Cooper, L., Liberman, D., Tucker, D., Neuchterlein, K. H., Tsuang, J., & Barnett, H. L. (1999). Neurocognitive deficits in the dually diagnosed with schizophrenia and cocaine abuse. Psychiatric Rehabilitation Skills, 3(2), 231-245. (15.8)

Corby, E. A., Roll, J. M., Ledgerwood, D. M., & Schuster, C. R. (2000). Contingency management interventions for treating the substance abuse of adolescents: A feasibility study. Experimental and Clinical Psychopharmacology, 8(3), 371-376. (27.3)

Covey, L. S., Joseph, A. M., & Shoptaw, S. (2003). Response: Getting tough with smoking. Science & Practice Perspectives, 2(1), 40-42. (17.10)

Crevecoeur, D., Finnerty, B. A., & Rawson, R. (2002). Los Angeles County Evaluation System (LACES): Bringing accountability to alcohol and drug abuse treatment through a collaboration between providers, payers, and researchers. Journal of Drug Issues, 32(3), 865-880. (13.33)

Last updated - 02/11/2010

Top of Page

2015 ISAP Publications
2014 ISAP Biennial Report